NCT07038590Completed
Use of Immersive Virtual Reality and Therapeutic Exercise as Complementary Therapy in Mild to Moderate Parkinson's Disease (InViPark)
Use of Immersive Virtual Reality and Therapeutic Exercise as Complementary Therapy in Mild to Moderate Parkinson's Disease (InViPark): Multicenter Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 3 Dec 2025
Brief summary (registry, in English)
This document is intended to provide participant with information about a research study in which the participant is invited to participate. This study was approved by the Research Ethics Committee of \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_. If the participant decide to participate, will receive personalized information from the investigator. Please read this document beforehand, and the investigator will ask you any questions you may have to understand the details. If the participant wish, the participant can take this document, review it with others, and take your time to decide whether or not to participate. Participation in this study is completely voluntary and free of charge. The participant can decide not to participate, participate, or change your mind by withdrawing your consent at any time during the project without giving any explanation. The investigators assure the participant that this decision will not affect any future participation with this research group. What is the purpose of the study? To analyze whether the use of a physical exercise program in immersive virtual environments (video games) has greater positive effects on Parkinson's symptoms than traditional rehabilitation programs. Why is the participant being offered to participate? The participant is invited to participate because the participant is a person diagnosed with Parkinson's and because, within the Open Science policies of the University of Vigo, the Galicia Sur Biomedical Foundation, and the Nóvoa Santos Foundation, where bringing research closer to the reality of patients is emphasized, the investigators have selected the specialized Parkinson's center of which the participant is a member to participate in this study. What does the participation consist of? The participation consists of carrying out 2/3 sessions per week on alternate days of physical exercise, and depending on whether the participant belong to the control or experimental group, the participant will do it regularly or recreated with a video game. The duration of each session will be 15 minutes. Be part of one group or another will depend on chance (like throwing a coin in the air and it comes up Heads or Cross). The total duration of the intervention in both cases is 3 months. During the project, 2 evaluations will be carried out: Initial evaluation and final evaluation. In all of them they will be collected information in relation to their pharmacological treatment linked to the pathology, autonomy functional balance, gait and risk of falls, functional balance, symptoms and disease monitoring and quality of life. Furthermore, in the experimental group the usability and security of the tool will be evaluated immersive virtual reality used. All these assessments will be carried out in your proximity center on the agreed day and time to optimize said process and will have an approximate duration of 30 minutes. What discomforts or inconveniences does the participation have? The participation requires travel to your reference center to carry out the study. This program, like any physical activity or exercise, may involve greater tiredness and/or musculo-articular discomfort due to the type of exercise to which you will be subjected. No relevant adverse effects have been recorded in the use of immersive virtual environments (video games).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 100 (actual)
- First submitted
- 16 Dec 2024
- Start date
- 5 Sept 2024
- Primary completion date
- 10 Dec 2024
- Lead sponsor
- University of Vigo
- Diseases
- Parkinson disease
- NCT number
- NCT07038590
What you commit to
- Study type: Interventional
- Participants enrolled: 100
- From 5 Sept 2024 to the primary completion date, 10 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Be receiving stable dopaminergic treatment without changes in the previous 3 months and with a prior plan not to change it during the duration of the study.
- Be receiving second-line therapy (deep brain stimulation or intraduodenal pump).
Other illness
- Having a history of vertigo, seizures, or epileptic seizures.
- Presence of motor fluctuations and/or dyskinesias, gait blockages, or a history of recent falls.
Other
- Comorbidity that makes physical exercise inadvisable and that prevents all scheduled assessments from being performed.
- Severe visual and/or hearing disturbances that impede the session.
- Be participating in another clinical trial.
- Not attend at least 80% of the immersive virtual reality sessions.
Who the study is looking for
- Suffering from idiopathic PD confirmed by a neurologist.
- Presenting a stage between 1 and 3 on the Hoehn and Yahr scale.
- Being able to move around unaided.
- Absence of dementia with a score on the Mini-Mental State Examination (MMSE) of 18 or higher.
- Being between 30 and 70 years of age.
Age in the registry: 30 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Vigo Coordinator of this site? Confirm its status | Pontevedra | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.